Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
First total synthesis of structurally unique flavonoids and their strong anti-inflammatory effectTakashi Nakatsuka, Yoshiaki Tomimori, Yoshiaki Fukuda, et al.
European Journal of Pharmacology|May 13, 2006
Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophilsMaki Terakawa, Yoshiaki Tomimori, Megumi Goto, et al.
The Journal of Investigative Dermatology|January 19, 2005
Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free conditionYoshiaki Tomimori, Yoshitaka Tanaka, Megumi Goto, et al.
Immunology Letters|October 15, 2003
Human chymase stimulates Ca2+ signaling in human polymorphonuclear cellsKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.
Biochemical and Biophysical Research Communications|May 28, 2005
Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathwayMaki Terakawa, Yoshiaki Tomimori, Megumi Goto, et al.
European Journal of Pharmacology|July 28, 2018
G protein-coupled receptor 39 plays an anti-inflammatory role by enhancing IL-10 production from macrophages under inflammatory conditionsSatoshi Muneoka, Megumi Goto, Kumiko Kadoshima-Yamaoka, et al.
Biological & Pharmaceutical Bulletin|June 7, 2019
G Protein-Coupled Receptor 39 Agonist Improves Concanavalin A-Induced Hepatitis in MiceSatoshi Muneoka, Megumi Goto, Tomonari Nishimura, et al.
European Journal of Pharmacology|May 26, 2019
ASB17061, a novel chymase inhibitor, prevented the development of angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient miceYoshiaki Tomimori, Atsushi Manno, Taisaku Tanaka, et al.
International Archives of Allergy and Immunology|July 18, 2002
Chymase inhibitor improves dermatitis in NC/Nga miceNaohiro Watanabe, Yoshiaki Tomimori, Kayo Saito, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitorsHiroshi Maruoka, Tsuyoshi Muto, Taisaku Tanaka, et al.
Pageof 3